{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:23:05Z","timestamp":1790896985338,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82302592"],"award-info":[{"award-number":["82302592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["Guangdong Basic and Applied Basic Research Foundation"],"award-info":[{"award-number":["Guangdong Basic and Applied Basic Research Foundation"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Nanshan District Scientific Research Program","award":["NSZD2024002"],"award-info":[{"award-number":["NSZD2024002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-03973-x","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:19:10Z","timestamp":1747376350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fingolimod as a potent anti-Staphylococcus aureus: pH-dependent cell envelope damage and eradication of biofilms\/persisters"],"prefix":"10.1186","volume":"25","author":[{"given":"Yongpeng","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"3","key":"3973_CR1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1128\/CMR.00081-09","volume":"23","author":"MZ David","year":"2010","unstructured":"David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. CLIN MICROBIOL REV. 2010;23(3):616\u201387.","journal-title":"CLIN MICROBIOL REV"},{"issue":"11","key":"3973_CR2","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/ijd.13010","volume":"54","author":"AK Gupta","year":"2015","unstructured":"Gupta AK, Lyons DC, Rosen T. New and emerging concepts in managing and preventing community-associated methicillin-resistant Staphylococcus aureus infections. INT J DERMATOL. 2015;54(11):1226\u201332.","journal-title":"INT J DERMATOL"},{"key":"3973_CR3","doi-asserted-by":"publisher","first-page":"104915","DOI":"10.1016\/j.micpath.2021.104915","volume":"156","author":"WT Liu","year":"2021","unstructured":"Liu WT, Chen EZ, Yang L, Peng C, Wang Q, Xu Z, Chen DQ. Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review. MICROB PATHOGENESIS. 2021;156: 104915.","journal-title":"MICROB PATHOGENESIS"},{"issue":"6","key":"3973_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jama.2020.0103","volume":"323","author":"S Tong","year":"2020","unstructured":"Tong S, Lye DC, Yahav D, Sud A, Robinson JO, Nelson J, Archuleta S, Roberts MA, Cass A, Paterson DL, et al. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal beta-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial. JAMA-J AM MED ASSOC. 2020;323(6):527\u201337.","journal-title":"JAMA-J AM MED ASSOC"},{"issue":"1","key":"3973_CR5","first-page":"56","volume":"9","author":"A Shariati","year":"2020","unstructured":"Shariati A, Dadashi M, Chegini Z, van Belkum A, Mirzaii M, Khoramrooz SS, Darban-Sarokhalil D. The global prevalence of Daptomycin, Tigecycline, Quinupristin\/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis. ANTIMICROB RESIST IN. 2020;9(1):56.","journal-title":"ANTIMICROB RESIST IN"},{"issue":"6499","key":"3973_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1126\/science.abd1225","volume":"369","author":"A Dal Co","year":"2020","unstructured":"Dal Co A, Brenner MP. Tracing cell trajectories in a biofilm. Science. 2020;369(6499):30\u20131.","journal-title":"Science"},{"key":"3973_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-micro-020518-115650","volume":"73","author":"B Gollan","year":"2019","unstructured":"Gollan B, Grabe G, Michaux C, Helaine S. Bacterial Persisters and Infection: Past, Present, and Progressing. ANNU REV MICROBIOL. 2019;73:359\u201385.","journal-title":"ANNU REV MICROBIOL"},{"issue":"3","key":"3973_CR8","doi-asserted-by":"publisher","first-page":"e00026","DOI":"10.1128\/MMBR.00026-19","volume":"84","author":"K Schilcher","year":"2020","unstructured":"Schilcher K, Horswill AR. Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies. Microbiology and molecular biology reviews: MMBR. 2020;84(3):e00026\u201319.","journal-title":"Microbiology and molecular biology reviews : MMBR"},{"issue":"1","key":"3973_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.chom.2019.06.002","volume":"26","author":"J Yan","year":"2019","unstructured":"Yan J, Bassler BL. Surviving as a Community: Antibiotic Tolerance and Persistence in Bacterial Biofilms. CELL HOST MICROBE. 2019;26(1):15\u201321.","journal-title":"CELL HOST MICROBE"},{"issue":"1","key":"3973_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nrmicro2474","volume":"9","author":"JG Hurdle","year":"2011","unstructured":"Hurdle JG, O\u2019Neill AJ, Chopra I, Lee RE. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. NAT REV MICROBIOL. 2011;9(1):62\u201375.","journal-title":"NAT REV MICROBIOL"},{"key":"3973_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3389\/fmicb.2018.01627","volume":"9","author":"H Chen","year":"2018","unstructured":"Chen H, Nyantakyi SA, Li M, Gopal P, Aziz DB, Yang T, Moreira W, Gengenbacher M, Dick T, Go ML. The Mycobacterial Membrane: A Novel Target Space for Anti-tubercular Drugs. FRONT MICROBIOL. 2018;9:1627.","journal-title":"FRONT MICROBIOL"},{"issue":"9","key":"3973_CR12","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/cid\/ciaa1081","volume":"72","author":"M Pujol","year":"2021","unstructured":"Pujol M, Miro JM, Shaw E, Aguado JM, San-Juan R, Puig-Asensio M, Pigrau C, Calbo E, Montejo M, Rodriguez-Alvarez R, et al. Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial. CLIN INFECT DIS. 2021;72(9):1517\u201325.","journal-title":"CLIN INFECT DIS"},{"issue":"10","key":"3973_CR13","doi-asserted-by":"publisher","first-page":"a025288","DOI":"10.1101\/cshperspect.a025288","volume":"6","author":"MJ Trimble","year":"2016","unstructured":"Trimble MJ, Mlyn\u00e1r\u010dik P, Kol\u00e1\u0159 M, Hancock RE. Polymyxin: Alternative Mechanisms of Action and Resistance. Cold Spring Harbor perspectives in medicine. 2016;6(10):a025288.","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"11","key":"3973_CR14","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/microorganisms8111834","volume":"8","author":"S Gilbert-Girard","year":"2020","unstructured":"Gilbert-Girard S, Savijoki K, Yli-Kauhaluoma J, Fallarero A. Screening of FDA-Approved Drugs Using a 384-Well Plate-Based Biofilm Platform: The Case of Fingolimod. Microorganisms. 2020;8(11):1834.","journal-title":"Microorganisms"},{"issue":"28","key":"3973_CR15","doi-asserted-by":"publisher","first-page":"18465","DOI":"10.1021\/acsomega.1c02591","volume":"6","author":"M Zore","year":"2021","unstructured":"Zore M, Gilbert-Girard S, Reigada I, Patel JZ, Savijoki K, Fallarero A, Yli-Kauhaluoma J. Synthesis and Biological Evaluation of Fingolimod Derivatives as Antibacterial Agents. ACS Omega. 2021;6(28):18465\u201386.","journal-title":"ACS Omega"},{"issue":"6","key":"3973_CR16","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1021\/acsinfecdis.1c00030","volume":"7","author":"J Zheng","year":"2021","unstructured":"Zheng J, Shang Y, Wu Y, Wu J, Chen J, Wang Z, Sun X, Xu G, Deng Q, Qu D, et al. Diclazuril Inhibits Biofilm Formation and Hemolysis of Staphylococcus aureus. ACS INFECT DIS. 2021;7(6):1690\u2013701.","journal-title":"ACS INFECT DIS"},{"issue":"7","key":"3973_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","volume":"17","author":"NQ Balaban","year":"2019","unstructured":"Balaban NQ, Helaine S, Lewis K, Ackermann M, Aldridge B, Andersson DI, Brynildsen MP, Bumann D, Camilli A, Collins JJ, et al. Definitions and guidelines for research on antibiotic persistence. NAT REV MICROBIOL. 2019;17(7):441\u20138.","journal-title":"NAT REV MICROBIOL"},{"issue":"2","key":"3973_CR18","doi-asserted-by":"publisher","first-page":"e0054121","DOI":"10.1128\/spectrum.00541-21","volume":"10","author":"Y Shang","year":"2022","unstructured":"Shang Y, Guo J, Zhao Y, Chen J, Meng Q, Qu D, Zheng J, Yu Z, Wu Y, Deng Q. Clemastine Inhibits the Biofilm and Hemolytic of Staphylococcus aureus through the GdpP Protein. Microbiology spectrum. 2022;10(2):e0054121.","journal-title":"Microbiology spectrum"},{"issue":"12","key":"3973_CR19","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/JCM.01643-09","volume":"47","author":"IG Bae","year":"2009","unstructured":"Bae IG, Tonthat GT, Stryjewski ME, Rude TH, Reilly LF, Barriere SL, Genter FC, Corey GR, Fowler VJ. Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J CLIN MICROBIOL. 2009;47(12):3952\u20137.","journal-title":"J CLIN MICROBIOL"},{"key":"3973_CR20","doi-asserted-by":"crossref","unstructured":"Lin Z, Pu Z, Xu G, Bai B, Chen Z, Sun X, Zheng J, Li P, Qu D, Deng Q, Yu Z. Omadacycline Efficacy against Enterococcus faecalis Isolated in China: In Vitro Activity, Heteroresistance, and Resistance Mechanisms. Antimicrobial agents and chemotherapy. 2020;64(3):e02097\u201319.","DOI":"10.1128\/AAC.02097-19"},{"issue":"1","key":"3973_CR21","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/s41467-018-03746-3","volume":"9","author":"WF Porto","year":"2018","unstructured":"Porto WF, Irazazabal L, Alves E, Ribeiro SM, Matos CO, Pires AS, Fensterseifer I, Miranda VJ, Haney EF, Humblot V, et al. In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design. NAT COMMUN. 2018;9(1):1490.","journal-title":"NAT COMMUN"},{"issue":"1","key":"3973_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1099\/jmm.0.001122","volume":"69","author":"JX Zheng","year":"2020","unstructured":"Zheng JX, Tu HP, Sun X, Xu GJ, Chen JW, Deng QW, Yu ZJ, Qu D. In vitro activities of telithromycin against Staphylococcus aureus biofilms compared with azithromycin, clindamycin, vancomycin and daptomycin. J MED MICROBIOL. 2020;69(1):120\u201331.","journal-title":"J MED MICROBIOL"},{"issue":"7","key":"3973_CR23","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.3390\/ijms22073384","volume":"22","author":"M Zajac","year":"2021","unstructured":"Zajac M, Dreano E, Edwards A, Planelles G, Sermet-Gaudelus I. Airway Surface Liquid pH Regulation in Airway Epithelium Current Understandings and Gaps in Knowledge. International journal of molecular sciences. 2021;22(7):3384.","journal-title":"International journal of molecular sciences"},{"key":"3973_CR24","doi-asserted-by":"crossref","unstructured":"Gagliotti C, Hogberg LD, Billstrom H, Eckmanns T, Giske CG, Heuer OE, Jarlier V, Kahlmeter G, Lo Fo Wong D, Monen J, Murchan S, Simonsen GS, \u0160ubelj M, Andra\u0161evi\u0107 AT, \u017babicka D, \u017demli\u010dkova H, Monnet DL, & EARS-Net study group participants.\u00a0Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU\/EEA, 2005 to 2018. Euro surveillance : bulletin Europeensur les maladies transmissibles = European communicable disease bulletin. 2021;26(46):2002094.","DOI":"10.2807\/1560-7917.ES.2021.26.46.2002094"},{"issue":"2","key":"3973_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/toxins12020119","volume":"12","author":"A Mairi","year":"2020","unstructured":"Mairi A, Touati A, Lavigne JP. Methicillin-Resistant Staphylococcus aureus ST80 Clone: A Systematic Review. Toxins. 2020;12(2):119.","journal-title":"Toxins"},{"issue":"1","key":"3973_CR26","doi-asserted-by":"publisher","first-page":"e0155921","DOI":"10.1128\/AAC.01559-21","volume":"66","author":"TH McConville","year":"2022","unstructured":"McConville TH, Austin ED, Geng W, Shi Q, Balasubramanian D, Kubin CJ, Torres VJ, Uhlemann AC. In Vitro Cytotoxicity and Clinical Correlates of MRSA Bacteremia. Antimicrobial agents and chemotherapy. 2022;66(1):e0155921.","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"3973_CR27","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2147\/IDR.S302416","volume":"14","author":"GJ Vazquez-Rosas","year":"2021","unstructured":"Vazquez-Rosas GJ, Merida-Vieyra J, Aparicio-Ozores G, Lara-Hernandez A, De Colsa A, Aquino-Andrade A. Molecular Characterization of Staphylococcus aureus Obtained from Blood Cultures of Paediatric Patients Treated in a Tertiary Care Hospital in Mexico. INFECT DRUG RESIST. 2021;14:1545\u201356.","journal-title":"INFECT DRUG RESIST"},{"issue":"15","key":"3973_CR28","doi-asserted-by":"publisher","first-page":"1802333","DOI":"10.1002\/advs.201802333","volume":"6","author":"VB Maisuria","year":"2019","unstructured":"Maisuria VB, Okshevsky M, Deziel E, Tufenkji N. Proanthocyanidin Interferes with Intrinsic Antibiotic Resistance Mechanisms of Gram-Negative Bacteria. ADV SCI. 2019;6(15):1802333.","journal-title":"ADV SCI"},{"key":"3973_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bcp.2016.09.025","volume":"133","author":"P Fernandes","year":"2017","unstructured":"Fernandes P, Martens E. Antibiotics in late clinical development. BIOCHEM PHARMACOL. 2017;133:152\u201363.","journal-title":"BIOCHEM PHARMACOL"},{"issue":"6","key":"3973_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1389450116666150806124110","volume":"17","author":"D Savoia","year":"2016","unstructured":"Savoia D. New Antimicrobial Approaches: Reuse of Old Drugs. CURR DRUG TARGETS. 2016;17(6):731\u20138.","journal-title":"CURR DRUG TARGETS"},{"issue":"2","key":"3973_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","volume":"33","author":"J Chun","year":"2010","unstructured":"Chun J, Hartung HP. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. CLIN NEUROPHARMACOL. 2010;33(2):91\u2013101.","journal-title":"CLIN NEUROPHARMACOL"},{"issue":"5","key":"3973_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue EW, O\u2019Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. NEW ENGL J MED. 2010;362(5):387\u2013401.","journal-title":"NEW ENGL J MED"},{"key":"3973_CR33","doi-asserted-by":"publisher","first-page":"627917","DOI":"10.3389\/fcimb.2021.627917","volume":"11","author":"LQ Wei","year":"2021","unstructured":"Wei LQ, Tan JC, Wang Y, Mei YK, Xue JY, Tian L, Song KY, Han L, Cui YC, Peng YB, et al. Fingolimod Potentiates the Antifungal Activity of Amphotericin B. FRONT CELL INFECT MI. 2021;11: 627917.","journal-title":"FRONT CELL INFECT MI"},{"issue":"11","key":"3973_CR34","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1128\/IAI.00281-20","volume":"88","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Xie L, Wang L, Xue M, Xu D, Zhong G, Roy CR. Effects of Immunomodulatory Drug Fingolimod (FTY720) on Chlamydia Dissemination and Pathogenesis. INFECT IMMUN. 2020;88(11):e220\u201381.","journal-title":"INFECT IMMUN"},{"issue":"6","key":"3973_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41579-019-0186-5","volume":"17","author":"S Mukherjee","year":"2019","unstructured":"Mukherjee S, Bassler BL. Bacterial quorum sensing in complex and dynamically changing environments. NAT REV MICROBIOL. 2019;17(6):371\u201382.","journal-title":"NAT REV MICROBIOL"},{"issue":"22","key":"3973_CR36","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1074\/jbc.RA119.012325","volume":"295","author":"R Verhaegh","year":"2020","unstructured":"Verhaegh R, Becker KA, Edwards MJ, Gulbins E. Sphingosine kills bacteria by binding to cardiolipin. J BIOL CHEM. 2020;295(22):7686\u201396.","journal-title":"J BIOL CHEM"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03973-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:19:14Z","timestamp":1747376354000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03973-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3973"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03973-x","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical review and approval were performed by the Medical Ethics Committee of Shanghai Pulmonary Hospital, School of Medicine (Ethical no. K23-088Y).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}